MMC Blood Cohort

  • Research type

    Research Study

  • Full title

    Molecular Mechanisms Cluster Blood cohort

  • IRAS ID

    344142

  • Contact name

    J Kenneth Baillie

  • Contact email

    j.k.baillie@ed.ac.uk

  • Sponsor organisation

    University of Edinburgh

  • Clinicaltrials.gov Identifier

    NA, NA

  • Duration of Study in the UK

    4 years, 0 months, 0 days

  • Research summary

    Cells, such as immune cells, respond to cues within the body or from the environment. Immune cells in blood for example respond to the presence of pathogens, such as bacteria and viruses, to counter these agents and respond to overcome infection. There is however differences between hoe people respond to infection and inflammation, where some people can develop very little symptoms, and some develop very severe symptoms. Some of this variation can be due to genetics. Understanding how differences in peoples genetics alter responses of immune cells to inflammation can help identify targets that can be developed into drugs to treat people with severe disease.
    This study will use blood from volunteers.
    Volunteers will be identified from within the University of Edinburgh, through promotional materials using email and posters. Initially, 150 participants will be part of the study over 3 years. After 150 participants, we will continue recruiting volunteers to be able to include people with more rare differences in their DNA. Volunteers will attend the Royal Infirmary of Edinburgh to donate 250 mls. of blood, approximately 17 tablespoons, about half of what would be donated with NHS blood donations. The blood will then be processed at a laboratory in the University of Edinburgh.
    The constituents of blood will be analysed for genes and genetic changes using DNA and RNA, the signals that encode how the body responds to the environment. Immune cells from blood will be treated with a variety of stimulations including inflammatory molecules in the lab to see how responses vary in a population of people. This will help understand how differences in DNA can alter cells responses and to develop new therapies.

  • REC name

    South East Scotland REC 02

  • REC reference

    25/SS/0011

  • Date of REC Opinion

    16 Apr 2025

  • REC opinion

    Further Information Favourable Opinion